Elekta AB (publ)

Elekta AB (publ)

0O5H.IL

Get informed when a big investor buys or sells

+ Follow
Market Cap$20.03B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Elekta AB (publ)Elekta AB (publ)-57.74.41%-7%1.31.8

Earnings Call Q3 2026

March 5, 2026 - AI Summary

Q3 performance: “solid quarter,” but FX/tariffs hit reported numbers - Net sales +2% YoY (Solutions +1%, Service +3%). - Gross margin 38.3%, +120 bps YoY; however tariffs ~ -100 bps and FX ~ -130 bps weighed on margins. - EBIT margin 11.9% (+20 bps YoY), but reported EBIT includes restructuring charge ~SEK 417m (items affecting comparability). - Big negative surprise for investors: FX moved rapidly; company estimates FX impact on Q3 net sales > SEK 500m negative, ~-12% growth impact in reported terms.
Orders & growth momentum: healthy book-to-bill; China returning to growth - Book-to-bill (Q3) 1.17 (vs 1.15 last year). Rolling 12-month book-to-bill 1.09 (healthy, though management wants higher). - Organic growth ~+2% YoY, driven mainly by Europe momentum and China returning to growth. - China outlook (management guidance): expects double-digit growth ~10% in H2 for both orders and revenue as the market recovers back toward pre-anti-corruption demand levels (units still below earlier peaks). - U.S. is improving off a low base: management notes substantial year-to-date order growth and that Evo approval was received Jan 16; order momentum should gradually convert via backlog.
Q4 and medium-term outlook: guidance reiterated; tariffs likely continue to pressure - Company reiterates 2025/26 outlook: expects net sales in constant currency to grow YoY. - Earnings outlook: expects tariff-related negative impact also in Q4 (no EBIT-margin or gross-margin guidance provided for Q4). - Midterm targets unchanged (company refers to confirming targets; specific numbers not restated in transcript). - Cash flow: Q3 cash flow weaker YoY, but year-to-date cash flow improved by >SEK 400m; they also mention net debt decrease >SEK 200m vs prior year’s Q3.

Exclusive for Stockcircle Pro members

Sign upSign Up
$47.90

Current Fair Value

15.6% downside

Overvalued by 15.6% based on the discounted cash flow analysis.

Share Statistics

Market cap$20.03 Billion
Enterprise Value$31.51 Billion
Dividend Yield$2.40 (4.41%)
Earnings per Share$-1.35
Beta1.07
Outstanding Shares382,083,120

Return

Return on Equity-7.48%ROE
Return on Assets-2.12%
Return on Invested Capital5.69%

Valuation & Multiples

P/E Ratio-57.69P/E Ratio
PEG-39.57PEG
Price to Sales1.32Price to Sales
Price to Book Ratio2.99Price to Book Ratio
Enterprise Value to Revenue1.9
Enterprise Value to EBIT45.25
Enterprise Value to Net Income-56
Total Debt to Enterprise0.44
Debt to Equity1.83Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
August 27, 2026
EPS Estimate
$0.47
Average shareholder expectation
Revenue Estimate
$3.63 B
Average shareholder expectation

Next Earnings Call

Expected Date
November 25, 2026
EPS Estimate
$0.84
Average shareholder expectation
Revenue Estimate
$4.15 B
Average shareholder expectation

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

ESG Score

No data

About Elekta AB

4,102 employees
CEO: Gustaf Salford

Elekta AB is a medical technology company. It engages in the provision of clinical solutions for the treatment of cancers and brain disorders. The firm's products and solutions include radiotherapy, stereotactic radiosurgery, oncology in...